Atossa Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $774.8K | $2.3M | $1.2M |
| Jun 2017 | $1.9M | $4.7M | $3.7M |
| Sep 2017 | $1.1M | $3.6M | $2.7M |
| Dec 2017 | $1.2M | $8.2M | $7.2M |
| Mar 2018 | $720.7K | $6.0M | $4.8M |
| Jun 2018 | $3.0M | $16.6M | $15.2M |
| Sep 2018 | $3.6M | $14.1M | $12.9M |
| Dec 2018 | $2.9M | $11.7M | $10.4M |
| Mar 2019 | $1.5M | $21.0M | $19.6M |
| Jun 2019 | $1.1M | $18.6M | $17.1M |
| Sep 2019 | $1.6M | $16.6M | $15.3M |
| Dec 2019 | $1.3M | $14.5M | $12.6M |
| Mar 2020 | $916.0K | $11.8M | $9.4M |
| Jun 2020 | $1.8M | $10.2M | $7.5M |
| Sep 2020 | $1.6M | $11.4M | $9.1M |
| Dec 2020 | $15.7M | $42.8M | $39.6M |
| Mar 2021 | $1.4M | $141.1M | $137.6M |
| Jun 2021 | $1.8M | $145.9M | $142.4M |
| Sep 2021 | $1.7M | $143.0M | $140.0M |
| Dec 2021 | $3.1M | $141.3M | $136.4M |
| Mar 2022 | $2.3M | $137.5M | $131.5M |
| Jun 2022 | $3.8M | $134.0M | $125.5M |
| Sep 2022 | $2.9M | $126.7M | $117.4M |
| Dec 2022 | $5.6M | $123.5M | $110.9M |
| Mar 2023 | $2.9M | $116.2M | $103.9M |
| Jun 2023 | $3.5M | $108.4M | $99.4M |
| Sep 2023 | $3.4M | $101.7M | $94.0M |
| Dec 2023 | $5.2M | $96.3M | $88.5M |
| Mar 2024 | $5.3M | $91.1M | $84.0M |
| Jun 2024 | $5.7M | $85.9M | $79.5M |
| Sep 2024 | $5.8M | $79.5M | $74.8M |
| Dec 2024 | $5.0M | $76.4M | $71.1M |
| Mar 2025 | $5.4M | $70.7M | $65.1M |
| Jun 2025 | $6.8M | $64.5M | $57.9M |
| Sep 2025 | $8.2M | $58.0M | $51.8M |
| Dec 2025 | $8.3M | $47.6M | $41.3M |
| Mar 2026 | $7.5M | $37.9M | $31.7M |
| Jun 2026 | $5.5M | $32.3M | $26.1M |